布加综合征的介入治疗研究进展

布加综合征是一种罕见的多病因疾病，临床表现可无症状、慢性或暴发性，其治疗应根据患者的病情采取逐步治疗策略。近年来，血管腔内介入治疗技术得到快速发展，依靠其安全、微创等优势，已成为布加综合征的首选治疗方式，其中，经皮腔内血管成形术、血管内支架植入术和经颈静脉肝内门体分流术在布加综合征的治疗中发挥重要价值。文章主要围绕布加综合征的介入治疗研究进展进行综述。

Research progress in interventional therapy for treatment of Budd-Chiari syndrome

Budd-Chiari syndrome (BCS) is an infrequent disease with multiple causes. Its clinical manifestations could be asymptomatic, chronic or fulminant. The treatment strategy for BCS should be taken step by step basing on the patient's condition. In recent years, endovascular interventional therapy technology has developed rapidly, relying on its advantages such as safe and minimally invasive, it has became the first treatment choice for BCS. Among them, percutaneous transluminal angioplasty (PTA) and endovascular stent implantation (ESI) and transjugular intrahepatic portosystemic shunt (TIPS) gradually play an important role in the treatment for BCS. This article will review the research progress of interventional therapy for BCS.